Treatment of murine primary neuron cultures with amyloid-β (Aβ)-42 peptides, the 42 kDa neurotoxic cleavage product of APP often found in Alzheimer's disease, stimulated ColVI expression via a TGF-β type II receptor-dependent mechanism. Here, APP is linked to Alzheimer disease.